Carcinogenesis is accompanied by widespread DNA methylation changes within the cell.
These changes are characterized by a globally hypomethylated genome with focal …

Bladder cancer is the most common malignancy of the urinary tract. Cystoscopy represents
the gold standard in the diagnosis of suspicious bladder lesions. However, the procedure is …

In light of the high incidence and mortality rates of cancer, early and accurate diagnosis is an
important priority for assigning optimal treatment for each individual with suspected illness …

The increase in recent scientific studies on cancer biomarkers has brought great new
insights into the field. Moreover, novel technological breakthroughs such as long read …

Bladder Cancer (BC) represents a clinical and social challenge due to its high incidence
and recurrence rates, as well as the limited advances in effective disease management …

Simple Summary The clinical management of bladder cancer has been developing in the
past decade, including diagnostic tools and treatment options. Both monotherapy and …

Bladder cancer (BC) is the tenth most frequent cancer worldwide and is associated with high
mortality when diagnosed in its most aggressive form, which is not reverted by the current …

Background Urinary biomarkers for the diagnosis of bladder cancer represents an area of
considerable research which has been tested in both patients presenting with haematuria …

Bladder cancer is one of the most common malignant tumors of the urinary system with a
significantly increased incidence in recent years. Tumor biomarkers detection with high …

Background State‐of‐art non‐invasive diagnosis processes for bladder cancer (BLCA)
harbour shortcomings such as low sensitivity and specificity, unable to distinguish between …